Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention

被引:76
|
作者
Patel, Rupa R. [1 ]
Mena, Leandro [2 ]
Nunn, Amy [3 ]
McBride, Timothy [4 ,5 ]
Harrison, Laura C. [1 ]
Oldenburg, Catherine E. [6 ]
Liu, Jingxia [7 ]
Mayer, Kenneth H. [8 ,9 ,10 ]
Chan, Philip A. [11 ]
机构
[1] Washington Univ St Louis, Div Infect Dis, St Louis, MO 63130 USA
[2] Univ Mississippi, Med Ctr, Div Infect Dis, Jackson, MS 39216 USA
[3] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI USA
[4] Washington Univ St Louis, Brown Sch, St Louis, MO USA
[5] Washington Univ St Louis, Ctr Hlth Econ & Policy, St Louis, MO USA
[6] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA
[7] Washington Univ St Louis, Div Publ Hlth Sci, St Louis, MO USA
[8] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA
[9] Harvard Med Sch, Dept Med, Boston, MA USA
[10] Fenway Hlth, Fenway Inst, Boston, MA USA
[11] Brown Univ, Div Infect Dis, Providence, RI 02912 USA
来源
PLOS ONE | 2017年 / 12卷 / 05期
基金
美国国家卫生研究院;
关键词
MEDICAID; CARE; ACCESS;
D O I
10.1371/journal.pone.0178737
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Pre-exposure prophylaxis (PrEP) can reduce U.S. HIV incidence. We assessed insurance coverage and its association with PrEP utilization. We reviewed patient data at three PrEP clinics (Jackson, Mississippi; St. Louis, Missouri; Providence, Rhode Island) from 2014-2015. The outcome, PrEP utilization, was defined as patient PrEP use at three months. Multivariable logistic regression was performed to determine the association between insurance coverage and PrEP utilization. Of 201 patients (Jackson: 34%; St. Louis: 28%; Providence: 28%), 91% were male, 51% were White, median age was 29 years, and 21% were uninsured; 82% of patients reported taking PrEP at three months. Insurance coverage was significantly associated with PrEP utilization. After adjusting for Medicaid-expansion and individual socio-demographics, insured patients were four times as likely to use PrEP services compared to the uninsured (OR: 4.49, 95% CI: 1.68-12.01; p = 0.003). Disparities in insurance coverage are important considerations in implementation programs and may impede PrEP utilization.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] HIV Pre-Exposure Prophylaxis
    Liegeon, Geoffroy
    Delaugerre, Constance
    Molina, Jean-Michel
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2024, 38 (03) : 453 - 474
  • [22] HIV: Pre-exposure Prophylaxis
    Singh, Ajai Kumar
    Singh, Ashish
    Singh, Deepti
    Singh, Manish
    Singh, Pratibha
    Sharma, Abhishek
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2012, 3 (12) : 900 - 901
  • [23] HIV pre-exposure prophylaxis
    Fougere, Edouard
    ACTUALITES PHARMACEUTIQUES, 2024, 63 (638): : 14 - 16
  • [24] HIV pre-exposure prophylaxis
    Morin, Stephen F.
    Yamey, Gavin
    Rutherford, George W.
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [25] Barriers to accessing HIV pre-exposure prophylaxis (PrEP) in Germany during health insurance coverage of PrEP
    Koppe, U.
    Marcus, U.
    Albrecht, S.
    Jansen, K.
    Gunsenheimer-Bartmeyer, B.
    Bremer, V.
    HIV MEDICINE, 2021, 22 : 278 - 278
  • [26] HIV Pre-exposure Prophylaxis (PrEP) - between Approval and Cost Coverage by the statutory Health Insurance Company
    Ahaus, P.
    Potthoff, A.
    Kayser, A.
    Wach, J.
    Brockmeyer, N. H.
    Skaletz-Rorowski, A.
    HAUTARZT, 2021, 72 (SUPPL 1): : S8 - S8
  • [27] Online Prescriptions to HIV Pre-Exposure Prophylaxis and Pre-Exposure Prophylaxis Uptake
    Wille, Lexie
    Parent, Mike C.
    AIDS PATIENT CARE AND STDS, 2020, 34 (12) : 499 - 501
  • [28] Pre-Exposure Prophylaxis - One More Tool for HIV Prevention
    Person, Anna K.
    Hicks, Charles B.
    CURRENT HIV RESEARCH, 2012, 10 (02) : 117 - 122
  • [29] Pre-exposure prophylaxis for HIV prevention in East and Southern Africa
    van der Wal, Ran
    Loutfi, David
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2017, 108 (5-6): : E643 - E645
  • [30] Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting
    Montgomery, Madeline C.
    Oldenburg, Catherine E.
    Nunn, Amy S.
    Mena, Leandro
    Anderson, Peter
    Liegler, Teri
    Mayer, Kenneth H.
    Patel, Rupa
    Almonte, Alexi
    Chan, Philip A.
    PLOS ONE, 2016, 11 (06):